High-risk subtypes, including T-ALL, KMT2A-r, BCR::ABL1, and BCR::ABL1-like ALL, were associated with elevated WBC counts, whereas patients with established low-risk subtypes, such as HeH and ETV6::RUNX1, exhibited the lowest WBC levels. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.